BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36476491)

  • 1. The role of procalcitonin in the follow-up of medullary thyroid cancer.
    Censi S; Manso J; Benvenuti T; Piva I; Iacobone M; Mondin A; Torresan F; Basso D; Crivellari G; Zovato S; Mian C
    Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36476491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows.
    Censi S; Di Stefano M; Repaci A; Benvenuti T; Manso J; Pagotto U; Iacobone M; Barollo S; Bertazza L; Galuppini F; Benna C; Pennelli G; Plebani M; Faggian D; Colombo C; Fugazzola L; Mian C
    Front Endocrinol (Lausanne); 2021; 12():754565. PubMed ID: 34721303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.
    Giovanella L; Garo ML; Ceriani L; Paone G; Campenni' A; D'Aurizio F
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3634-3643. PubMed ID: 34382653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
    Ittner L; Born W; Rau B; Steinbach G; Fischer JA
    Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary and serum biomarkers of inflammation in a man with metastatic medullary thyroid carcinoma and hyperreactive gingiva: a fourteen year odyssey.
    Redman RS; Bayley NC; Nylén ES
    Biotech Histochem; 2019 Aug; 94(6):389-397. PubMed ID: 31423894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
    Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
    Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of calcitonin and procalcitonin Elecsys
    Giovanella L; Fontana M; Keller F; Verburg FA; Ceriani L
    Clin Chem Lab Med; 2021 Mar; 59(4):743-747. PubMed ID: 33085633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma.
    Kratzsch J; Willenberg A; Frank-Raue K; Kempin U; Rocktäschel J; Raue F
    Clin Chem Lab Med; 2021 Oct; 59(11):1861-1868. PubMed ID: 34256421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
    Lim SK; Guéchot J; Vaubourdolle M
    Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.
    Algeciras-Schimnich A; Preissner CM; Theobald JP; Finseth MS; Grebe SK
    J Clin Endocrinol Metab; 2009 Mar; 94(3):861-8. PubMed ID: 19088163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
    Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
    Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin as Marker of Recurrent Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Trimboli P; Giovanella L
    Endocrinol Metab (Seoul); 2018 Jun; 33(2):204-210. PubMed ID: 29947178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
    Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization.
    Snider RH; Nylen ES; Becker KL
    J Investig Med; 1997 Dec; 45(9):552-60. PubMed ID: 9444882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
    Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
    Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays.
    Faggiano A; Giannetta E; Modica R; Albertelli M; Barba L; Dolce P; Motta C; Deiana MG; Martinelli R; Zamponi V; Sesti F; Patti L; Scavuzzo F; Colao A; Monti S
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):253-260. PubMed ID: 37326573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
    Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
    Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
    Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.